----

----

|     Colorado                                    |   | 84-1509950                        |
|---------------------------------------------------------------------|--------|-----------------------------------|
| (State or other jurisdictionof incorporation or organization)  |   | (IRS Employer Identification No.) |

----

| PART I.    FINANCIAL INFORMATION                                                                                   |   |
|----------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                   |   |
| Item 1.      Consolidated Financial Statements                                                                | 3      |
|                                                                                                                                   |   |
| Consolidated Balance Sheet                                                                                                             | 3      |
|                                                                                                                                   |   |
| Consolidated Statements of Operations,                                                                                                 | 5      |
|                                                                                                                                   |   |
| Consolidated Statements of Cash Flows                                                                                                  | 6      |
|                                                                                                                                   |   |
| Consolidated Statements of Comprehensive Loss                                                                                          | 7      |
|                                                                                                                                   |   |
| Consolidated Statement of Stockholders’ (Deficit)                                                                                | 8      |
|                                                                                                                                   |   |
| Notes to Unaudited Consolidated Financial Statements                                                                                   | 9      |
|                                                                                                                                   |   |
| Item 2.       Management's Discussion and Analysis of Financial Condition and Results of Operations | 13     |
|                                                                                                                                   |   |
| Item 3.       Quantitative and Qualitative Disclosures About Market Risk                            | 18     |
|                                                                                                                                   |   |
| Item 4.       Controls and Procedures                                                               | 18     |
|                                                                                                                                   |   |
| Part II. OTHER INFORMATION                                                                                                             |   |
|                                                                                                                                   |   |
| Item 1        Legal Proceedings                                                                | 19     |
|                                                                                                                                   |   |
| Item 1A.    Risk Factors                                                                                                | 19     |
|                                                                                                                                   |   |
| Item 2.       Unregistered Sales of Equity Securities and Use of Proceeds                           | 19     |
|                                                                                                                                   |   |
| Item 3.       Defaults upon Senior Securities                                                       | 19     |
|                                                                                                                                   |   |
| Item 4.       (Removed and Reserved)                                                                | 19     |
|                                                                                                                                   |   |
| Item 5.       Other Information                                                                          | 19     |
|                                                                                                                                   |   |
| Item 6.       Exhibits                                                                              | 19     |
|                                                                                                                                   |   |
| SIGNATURES                                                                                                                             | 20     |
|                                                                                                                                   |   |

----

|              |   | March 31,2011 |     |   | September 30,2010 |   |
|--------------------------------------------------------------------------|--------|---------------|----------|--------|-------------------|--------|
|                                                                     |   | (Unaudited)   |     |   | (Audited)         |   |
| Assets                                                                   |   |          |     |   |              |   |
| Current Assets                                                           |   |          |     |   |              |   |
| Cash and cash equivalents                                                |   | $             | 153,045  |   |              | $      | 26,716 |   |
| Accounts receivable                                                      |   |          | 15,659   |   |              |   | 12,809 |   |
| Inventories                                                              |   |          | 263,053  |   |              |   | 224,223 |   |
| Prepaid expenses                                                         |   |          | 31,512   |   |              |   | 20,200 |   |
|                                                                     |   |          |     |   |              |   |   |   |
| Total Current Assets                                                     |   |          | 463,269  |   |              |   | 283,948 |   |
|                                                                     |   |          |     |   |              |   |   |   |
|                                                                     |   |          |     |   |              |   |   |   |
| Long Term Investment                                                     |   |          |     |   |              |   |   |   |
| Investment in MIT China Joint Venture                                    |   |          | 327,600  |   |              |   |      348,434 |   |
|                                                                     |   |          |     |   |              |   |   |   |
| Property and Equipment                                                   |   |          |     |   |              |   |   |   |
| Tooling and machinery                                                    |   |          | 331,404  |   |              |   | 301,995 |   |
| Furniture and office equipment                                           |   |          | 150,392  |   |              |   | 141,600 |   |
| Leasehold improvements                                                   |   |          | 30,941   |   |              |   | 29,132 |   |
|                                                                     |   |          | 512,737  |   |              |   | 472,727 |   |
|                                                                     |   |          |     |   |              |   |   |   |
| Less accumulated depreciation                                            |   |          | (470,912 | )      |              |   | (451,779 | ) |
|                                                                     |   |          | 41,825   |   |              |   | 20,948 |   |
| Other Assets                                                             |   |          |     |   |              |   |   |   |
| Patents (net of accumulated amortization of $3,986 and $6,193)           |   |          | 27,548   |   |              |   | 14,834 |   |
|      Total assets                               |   | $             | 860,242  |   |              | $      | 668,164 |   |

----

| CONSOLIDATED BALANCE SHEET |
|----------------------------|
|                       |   |

|                                                                                                                                 |   | March 31 2011 |                                              |   | September 30 2010 |    |
|--------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------|---------------------------------------------------|--------|------------------------|---------|
|                                                                                                                                 |   | (Unaudited)        |                                              |   | (Audited)              |    |
| Liabilities and Stockholders' Equity (Deficit)                                                                                       |   |               |                                              |   |                   |    |
| Current Liabilities                                                                                                                  |   |               |                                              |   |                   |    |
|         Deferred income                                                                           |   |  $            | 1,084,846                                         |   |                   |  $ | 1,078,009 |   |
|         Accounts payable and accrued expenses                                                     |   |               | 110,435                                           |   |                   |    | 312,303 |   |
|         Amounts due to related parties                                                            |   |               | 189,839                                           |   |                   |    | 178,767 |   |
|         Amounts due to shareholders                                                          |   |               |        303,117 |   |                   |    |   - |   |
|                                                                                                                                 |   |               | 1,688,237                                         |   |                   |    | 1,569,079 |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Total Liabilities                                                                                                                    |   |               | 1,688,237                                         |   |                   |    | 1,569,079 |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Stockholders' Equity (Deficit)                                                                                                       |   |               |                                              |   |                   |    |   |   |
| Preferred stock, $.0001 par value; 3,000,000 shares authorized; None issued and outstanding as of December 31, 2007                  |   |               |                                              |   |                   |    |   |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Common stock, $.0001 par value; 100,000,000 shares authorized; 68,030,295 and 66,260,295 shares issued and Outstanding, respectively |   |               | 6,774                                             |   |                   |    | 6,626 |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Additional paid-in capital                                                                                                           |   |               | 12,109,596                                        |   |                   |    | 11,931,996 |   |
| Deficit                                                                                                                              |   |               | (12,509,183                                       | )      |                   |    | (12,418,732 | ) |
| Other comprehensive income (loss)                                                                                                    |   |               | (435,182                                          | )      |                   |    | (420,805 | ) |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Total Stockholders' Equity (Deficit)                                                                                                 |   |               | (827,995                                          | )      |                   |    | (900,915 | ) |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
| Total Liabilities and Stockholders' Equity (Deficit)                                                                                 |   |  $            | 860,242                                           |   |                   | $       | 668,164 |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |
|                                                                                                                                 |   |               |                                              |   |                   |    |   |   |

----

|                                                                    |   | Three-Months PeriodEnded March 31, |                                                                             |   | Six-Months Period Ended March 31, |   |
|-------------------------------------------------------------------------|--------|------------------------------------|----------------------------------------------------------------------------------|--------|----------------------------------------|--------|
|                                                                    |   | 2011(Unaudited)                    |                                                                             |   | 2010(Unaudited)                        |   |   | 2011(Unaudited) |   |   | 2010(Unaudited) |   |
| Sales                                                                   |   | $                                  | 136,070                                                                          |   |                                   | $      | 144,557 |   |   | $ | 201,255 |   |   | $ | 353,120 |   |
| Cost of sales                                                           |   |                               |             (39,564) |   |                                   |   | ( 43,588 | ) |   |   | (66,006 | ) |   |   | (98,579 | ) |
| Gross profit (loss)                                                     |   |                               | 96,506                                                                           |   |                                   |   | 100,969 |   |   |   | 135,249 |   |   |   | 254,541 |   |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Research and development costs                                          |   |                               | -                                                                                |   |                                   |   | (74,017 | )  |   |   | - |   |   |   |       (76,484) |   |
| Selling, general, and administrative expenses                           |   |                               | ( 113,685                                                                        | )      |                                   |   | (513,927 | )  |   |   | (197,646 | ) |   |   | (797,201 |  ) |
|                                                                    |   |                               | (113,685                                                                         | )      |                                   |   | (587,944 | )  |   |   | (197,646 | ) |   |   | (873,685 | )  |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|  Loss from operations                                              |   |                               | (17,179                                                                          | )      |                                   |   | (486,975 | ) |   |   | (62,397 | ) |   |   | (619,144 | ) |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Other Income (Expense)Equity earnings (loss) on MIT China Joint Venture |   |                               | 4,848                                                                            |   |                                   |   | (50,077 | )  |   |   | (20,834  | )  |   |   | (50,077 | )  |
| Interest income/loss                                                    |   |                               | -                                                                                |   |                                   |   | (588 | )  |   |   | - |   |   |   | - |   |
| Interest expense                                                        |   |                               | (6,533                                                                           | )      |                                   |   | (232 | ) |   |   | (7,220 | ) |   |   | (6,476 | ) |
|                                                                    |   |                               | (1,685                                                                           | )      |                                   |   | (50,897 | )  |   |   | (28,054 | ) |   |   | (56,553 | ) |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Net Loss                                                                |   | $                                  | (18,864                                                                          | )      |                                   | $      | (537,872 | ) |   | $ | (90, 451 | ) |   | $ | (675,679 | ) |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Basic (loss) per share                                                  |   | $                                  | (0.00                                                                            | )      |                                   | $      | (0.01 | ) |   | $ | (0.001 | ) |   | $ | (0.01 | ) |
|                                                                    |   |                               |                                                                             |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Basic weighted average shares outstanding                               |   |                               | 68,030,295                                                                       |   |                                   |   | 69,357,795 |   |   |   | 68,030,295 |   |   |   | 62,297,795 |   |

----

|                                                                                        |   | Six-Month Period Ended |                                                                |
|---------------------------------------------------------------------------------------------|--------|------------------------|---------------------------------------------------------------------|
|                                                                                        |   | March 31,              |                                                                |   | March 31, |   |
|                                                                                        |   | 2011                   |                                                                |   | 2010 |   |
| Cash flows from operating activities:                                                       |   |                   |                                                                |   |   |   |
| Net loss                                                                                    |   | $                      | (90, 451                                                            | ) |   | $ | (675,697 | ) |
| Adjustments to reconcile net loss to net cash                                               |   |                   |                                                                |   |   |   |   |   |
|   provided by (used in) operating activities:                                     |   |                   |                                                                |   |   |   |   |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
|     Equity loss from MIT China Joint Venture                            |   |                   | 20,834                                                              |   |   |   |                              50,077 |   |
|     Depreciation and amortization expense                               |   |                   | 13,814                                                              |   |   |   | 11,533 |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
|     Common stock issued for services                                    |   |                   | 1,000                                                               |   |   |   | 333,400 |   |
|     Related party payables settle by common stock                       |   |                   |            - |   |   |   |        - |   |
|     Capitalization of related party debts                               |   |                   |                                                                |   |   |   |   |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
| Changes in:                                                                                 |   |                   |                                                                |   |   |   |   |   |
|     Accounts receivable                                                 |   |                   | (2,850                                                              | ) |   |   | 5,243 |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
|     Inventories                                                         |   |                   | (38,830                                                             | ) |   |   | (27,156 | )  |
|     Prepaid expenses                                                    |   |                   | (11,312)                                                            |   |   |   | (233 | ) |
|     Accounts payable and accrued liabilities                            |   |                   | (201,868                                                            | ) |   |   | 119,884 |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
|     Deferred income                                                     |   |                   | 6,837                                                               |   |   |   | (56,960 | ) |
|          Net cash used by operating activities |   |                   | (302,826                                                            | ) |   |   | (239,909 | ) |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
| Cash flows from investing activities:                                                       |   |                   |                                                                |   |   |   |   |   |
|     Acquisition of patents                                              |   |                   | (10,524                                                             | ) |   |   | (11,386) |   |
|     Investment in MIT China joint venture                               |   |                   | -                                                                   |   |   |   | (10,437 | ) |
|     Tooling and machinery                                               |   |                   | (10,659                                                             | )  |   |   | - |   |
|         Net cash used by investing activities       |   |                   | (21,183                                                             | ) |   |   |       (21,823 | ) |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
| Cash flows from financing activities:                                                       |   |                   |                                                                |   |   |   |   |   |
|    Proceeds from issuance of stock, net                                      |   |                   | 158,017                                                             |   |   |   | 100,000 |   |
|    Increase in amounts due to related parties                                |   |                   | 314,189                                                             |   |   |   | 219,215 |   |
|    Issuance of notes payable                                                 |   |                   | -                                                                   |   |   |   | - |   |
|    Repayment on notes payable                                                |   |              | -                                                                   |   |   |    |        (3,474 | ) |
|         Net cash provided from financing activities |   |                   | 472,206                                                             |   |   |   | 315,741 |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
| Effect of exchange rates                                                                    |   |                   | (21,868                                                             | ) |   |   | (78,390 | )  |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
|                                                                                        |   |                   |                                                                |   |   |   |   |   |
| Increase (decrease) in cash                                                                 |   |                   | 126,329                                                             |   |   |   | (24,381) |   |
| Cash, beginning of period                                                                   |   |                   | 26,716                                                              |   |   |   | 77,461 |   |
| Cash, end of period                                                                         |   | $                      | 153,045                                                             |   |   | $ | 53,080 |   |
| Supplemental disclosure of cash flow information:                                           |   |                   |                                                                |   |   |   |   |   |
|     Cash paid for interest                                              |   | $                      | 7,220                                                               |   |   | $ | 6,476 |   |
|     Cash paid for federal income taxes                                  |   | $                      | -                                                                   |   |   | $ | - |   |
| Supplemental disclosure of non-cash transactions                                            |   |                   |                                                                |   |   |   |   |   |
|    Common stock issued for debt reductions                                   |   | $                      | -                                                                   |   |   | $ | - |   |

----

| CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
|-----------------------------------------------|

|                                                                 |   | Second quarter endingMarch 31,2011 |     |   | Second quarter endingMarch 31,2010 |   |
|----------------------------------------------------------------------|--------|------------------------------------|----------|--------|------------------------------------|--------|
| Net loss                                                             |   | $                                  | (90,451  | )      |                               | $      | (675,697 | ) |
| Other comprehensive income (loss)                                    |   |                               |     |   |                               |   |   |   |
| Foreign currency translation adjustment                              |   |                               | (14,377) |   |                               |   | (75,825) |   |
|                                                                 |   |                               |     |   |                               |   |   |   |
|        Net comprehensive income (loss) |   | $                                  | (104,828 | )      |                               | $      | (751,522 | ) |

----

| CONSOLIDATED STATEMENT OF STOCKHOLDERS’ (DEFICIT) |
|---------------------------------------------------------|

|                                                    |   | Common Stock |       |   | Additional Paid in |   |
|---------------------------------------------------------|--------|--------------|------------|--------|--------------------|--------|
|                                                    |   | Shares       |       |   | Amount             |   |   | Capital |   |   | Deficit |   |
|                                                    |   |         |       |   |               |   |   |   |   |   |   |   |
| Balance – September 30, 2010                      |   |         | 66,260,295 |   |               | $      | 6,626 |   |   | $ | 11,931,996 |   |   | $ | (12,418,733 | ) |
|                                                    |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Shares issued for debts                                 |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | - |   |
| Shares issued for services                              |   |         | 10,000     |   |               |   | 1 |   |   |   | 999 |   |   |   | - |   |
| Shares issued for additional capital                    |   |         | 1,760,000  |   |               |   | 147 |   |   |   | 176,601 |   |   |   | - |   |
|                                                    |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Net loss for the period ended December 31, 2010         |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | (71,587 | ) |
| Balance – December 31, 20010                      |   |         | 68,030,295 |   |               | $      | 6,774 |   |   | $ | 12,190,596 |   |   | $ | (12,490,320 |   |
|                                                    |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Net loss for the period ended March  31, 2011 |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | (18,864) |   |
| Balance – March 31, 2011                          |   |         | 68,030,295 |   |               |   | 6,774 |   |   |   | 12,109,596 |   |   |   | (12,509,184 | ) |

----

|            |   | March 31,2011 |    |   | September 30,2010 |   |
|-----------------|--------|---------------|---------|--------|-------------------|--------|
| Raw materials   |   | $             | 189,922 |   |              | $      | 166,611 |   |
| Work in process |   |          | 52,519  |   |              |   | 47,259 |   |
| Finished goods  |   |          | 20,612  |   |              |   | 10,353 |   |
| Total           |   | $             | 263,053 |   |              | $      | 224,223 |   |

----

|    |   | GrossIntangibleAssets |   |   | Accumulated Amortization |   |   | Net IntangibleAssets |   | WeightedAverageLife(Years) |
|---------|--------|-----------------------|--------|--------|--------------------------|--------|--------|---------------------------|--------|----------------------------|
| Patents |   | $                     | 33,741 |   |                     | $      | 6,193  |                      |   | $                          | 27,548 |   | 8.5 through 16 |

|                            |   | March 31,2011 |                            |   | September 30,2010 |   |
|---------------------------------|--------|---------------|---------------------------------|--------|-------------------|--------|
| Payable to 2849-674 Canada Inc  |   | $             | 72,195                          |   |              | $      | 67,974 |   |
| Payable to Pascal D'Onofrio     |   |          |     37,6444 |   |              |   |          30,793 |   |
| Payable to 9211-0766 Quebec Inc |   |          | 80,000                          |   |              |   |          80,000 |   |
|                            |   |          |                            |   |              |   |   |   |
|                            |   | $             | 189,839                         |   |              | $      | 178,767 |   |

----

----

----

----

----

----

----

----

----

----

|                                             | Medical International Technology, Inc. |                                          |
|--------------------------------------------------|----------------------------------------|-----------------------------------------------|
|                                             |                                   |                                          |   |
| Date: May 14, 2011      | By:                                    | /s/ Karim Menassa                   |   |
|                                             |                                   | Karim Menassa                                 |   |
|                                             |                                   | President and Principal Executive Officer     |   |
|                                             |                                   | Interim Secretary and Chief Financial Officer |   |

----